Comparison of a newly developed high performance liquid chromatography method with diode array detection to a liquid chromatography tandem mass spectrometry method for the quantification of cabozantinib, dabrafenib, nilotinib and osimertinib in human serum - Application to therapeutic drug monitoring.
Clin Biochem
; 105-106: 35-43, 2022.
Article
de En
| MEDLINE
| ID: mdl-35483452
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Surveillance des médicaments
/
Spectrométrie de masse en tandem
Type d'étude:
Diagnostic_studies
Limites:
Humans
Langue:
En
Journal:
Clin Biochem
Année:
2022
Type de document:
Article
Pays d'affiliation:
Allemagne